Cullinan Oncology, Inc. is a biopharmaceutical company focused on the discovery and advancement of life-saving oncology treatments, operating from Massachusetts.
Operating in the dynamic and complex healthcare sector, this company is intricately involved in the field of oncology. Its services are centred around developing and commercialising novel, targeted cancer treatments, harnessing advanced technology and science to create solutions that can provide better outcomes for patients. Cullinan Oncology is not part of any larger organisation and has no subsidiaries.
Monitor the CGEM share price by adding it to your eToro watchlist.